{"schema_version":"secwatch.filing_event.v1","accession":"0001999480-26-000024","form_type":"8-K","ticker":"ANRO","cik":"0001999480","company_name":"Alto Neuroscience, Inc.","filed_at":"2026-08-27T21:18:31+00:00","discovered_at":"2026-08-27T21:20:00.504359+00:00","generated_at":"2026-08-27T21:20:08.166152+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Alto Neuroscience promotes CFO Nicholas Smith to President and CFO; Etkin stays CEO","bullets":["Effective Aug 26, 2026, Nicholas C. Smith promoted from CFO/CBO to President and CFO.","Amit Etkin remains CEO but no longer President; stays principal executive officer.","Smith receives $6M retention payment: $3M within 10 days, $3M at 12-month anniversary.","Retention payment requires 2-year employment; repayment if resignation or termination for cause.","Agreement filed as Exhibit 10.1; no family relationships or Item 404(a) transactions."],"urls":{"canonical":"https://secwatch.observer/filing/0001999480-26-000024","json":"https://secwatch.observer/filing/0001999480-26-000024.json","markdown":"https://secwatch.observer/filing/0001999480-26-000024.md","text":"https://secwatch.observer/filing/0001999480-26-000024.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1999480/000199948026000024/0001999480-26-000024-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1999480/000199948026000024/alto-20260826.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-27T21:20:08.166152+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}